IDH1 and neoplasm: Moreover, the identification and quantification of metabolic products such as trimetilamin-N-oxide, N-atsetilputrestsin, and uridine by mass spectrometry helps to identify key differences between healthy and tumor tissue, making a step ahead for a correct tumor staging and a fast identification of IDH mutations [187,188].